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papillary muscle. In the 5 long term survivors, the implanted device showed satisfactory healing, no inflammatory or toxicity response, and no chordae dehiscence.  CONCLUSIONS:  Transcatheter minimally-invasive, beating-heart implantation of a sutureless neochordae implant is feasible.  This approach may be an alternative to open surgical procedures in high risk degenerative MR patients or even in young patients who want to avoid an operation.   
    
